CommercialPrior AuthMedium impact

Preauthorization Updates

Q: Who is affected by this change?

This affects EmblemHealth Oncology, Hematology, Rheumatology, Gastroenterology, Neurology, Infectious Disease providers on Commercial plans.

EmblemHealth·Oncology, Hematology, Rheumatology +3 more·Prior Authorization

Effective date

Not stated

We identified it

Jun 20, 2026

Days to comply

—

Summary

EmblemHealth and ConnectiCare have updated their Pharmacy Medical Preauthorization Lists to reflect new Infusion Site of Service policy requirements. This affects where infusion services can be provided and what prior authorization is needed.

Action Required

Action needed

Immediately: Review updated Pharmacy Medical Preauthorization Lists for EmblemHealth and ConnectiCare at the source URL. Update prior authorization workflows to comply with new Infusion Site of Service requirements. Verify approved sites of service for infusion therapies before scheduling patients.

Related policy hubs

EmblemHealth policies Oncology Hematology Rheumatology Gastroenterology Neurology Infectious Disease